ARTICLE | Company News
Idec and Taisho antibody deal
June 28, 2000 7:00 AM UTC
The companies will develop and market IDPH 's antibody therapeutics against macrophage migration inhibitory factor (MIF) to treat inflammatory and autoimmune diseases. IDPH is responsible for developm...